Regeneron Pharmaceuticals Inc REGN:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD

Last | 3:37 PM EDT

985.06

+8.10 (+0.83%)

Volume

192,517

52 week range

684.80 - 998.33

Open980.00
Day High987.38
Day Low970.95
Prev Close976.96
52 Week High998.33
52 Week High Date02/28/24
52 Week Low684.80
52 Week Low Date06/28/23

Key Stats

Market Cap108.539B
Shares Out110.19M
10 Day Average Volume0.49M
Dividend-
Dividend Yield-
Beta0.12
YTD % Change12.15

KEY STATS

Open980.00
Day High987.38
Day Low970.95
Prev Close976.96
52 Week High998.33
52 Week High Date02/28/24
52 Week Low684.80
52 Week Low Date06/28/23
Market Cap108.539B
Shares Out110.19M
10 Day Average Volume0.49M
Dividend-
Dividend Yield-
Beta0.12
YTD % Change12.15

RATIOS/PROFITABILITY

EPS (TTM)33.86
P/E (TTM)29.09
Fwd P/E (NTM)22.02
EBITDA (TTM)4.425B
ROE (TTM)15.28%
Revenue (TTM)13.10B
Gross Margin (TTM)86.32%
Net Margin (TTM)29.45%
Debt To Equity (MRQ)10.02%

EVENTS

Earnings Date08/01/2024(est)
Ex Div Date-
Div Amount-
Split Date-
Split Factor-

Latest On Regeneron Pharmaceuticals Inc

Calls of the Day: Roblox, Regeneron, Costco and Edison3 Hours AgoCNBC.com
Evercore ISI sees an end to 3 years of biotech underperformance, gives 5 top stocks4 Hours AgoCNBC.com
Tuesday's top analyst calls: Apple, Nvidia, Amazon, Tesla, Planet Fitness7 Hours AgoCNBC.com
Morgan Stanley says these stocks could follow Meta in announcing a dividendMay 10, 2024CNBC.com
When Tesla shares rise — these 7 stocks have tended to rise too recentlyApril 24, 2024CNBC.com

Content From Our Affiliates

Profile

Regeneron Pharmaceuticals, Inc. is a fully integrated biotechnology company. The Company invents, develops, manufactures, and commercializes medicines for people with serious diseases. Its products and product candidates in development are designed to help patients with eye diseases, allergic and inflammatory diseases, cancer, cardiovascular and metabolic diseases, neurological diseases, hematologic conditions, infectious diseases, and rare diseases. The Company helps in...

Christopher Fenimore

Chief Financial Officer, Senior Vice President - Finance

Daniel Van Plew

Executive Vice President, General Manager - Industrial Operations and Product Supply

Marion McCourt

Executive Vice President - Commercial

Andrew Murphy Ph.D.

Executive Vice President - Research

Neil Stahl Ph.D.

Executive Vice President - Research and Development

Jason Pitofsky

Vice President, Controller

Address

777 Old Saw Mill River Road

Tarrytown, NY

10591

United States

https://www.regeneron.com/

Top Peers

SYMBOL	LAST	CHG	%CHG
BIIB Biogen Inc	226.34	+1.00	+0.44%
MRNA Moderna Inc	127.45	+1.78	+1.42%
NVZMY Novozymes A/S	61.00	+0.55	+0.91%
ILMN Illumina Inc	115.38	+2.61	+2.31%
GRFS Grifols SA	7.51	+0.22	+3.09%